Publications and Abstracts

Articles

  1. Van Den Berg, C., McGill, J.R., Kuhn, J.G., Walsh, J.T., De La Cruz, P.S., Davidson, K.K., Wahl, G.M., Von Hoff, D.D. Pharmacokinetics of hydroxyurea in nude mice. Anti-Cancer Drugs 1994; 5: 573-8.
  2. Weiss, G.R., Kuhn, J.G., Rizzo, J., Smith, L.S., Rodriguez, G.I., Eckardt, J., Burris, H.A., III, Fields, S., Van Den Berg, K., Von Hoff, D.D. A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid cancers. Cancer Chemother Pharmacol 1994; 35: 397-402.
  3. Van Den Berg, C., Guan, X-Y, Von Hoff, D., Jenkins, R., Bittner, M., Griffin, C., Kallonemi, O., Visakorpi, T., McGill J., Hearth, J., Epstein, J., Sarosdy, M., Meltzer, P., Trent, J. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: Potential prognostic implications. Clinical Cancer Res 1994; 1: 11-18.
  4. Koeller, J.M., Van Den Berg, C.L. Anemias. In: Yee Young L, Koda-Kimble MA, eds. Applied Therapeutics. 6th ed. Vancouver:Applied Therapeutics; 1995:88-1-17.
  5. Van Den Berg, C.L., von Hoff, D.D. “Use of hydroxyurea to alter drug resistance of human tumor cells” In: Mugia FM, ed., Chemotherapy: concepts, mechanisms, and disease targets. Kluwer Academic Publishers; 1995:95-114.
  6. Yee, D., Van Den Berg, C., Kozelsky, T.W., Kuhn, J.G., Cox, G.N. Pharmacokinetic profile of recombinant human insulin-like growth factor binding protein-1 in athymic mice. Biomedicine & Pharmacotherapy 1996; 50: 154-157.
  7. Van Den Berg, C.L., Kuhn, J.G., Hilsenbeck, S., Cox, G.N., Yee, D. Insulin-like growth factor binding protein-1 (rhIGFBP-1) inhibits growth of breast cancer in athymic mice. Eur Jnl Cancer 1997; 33: 1108-1113.
  8. Rocha, R.L., Hilsenbeck, S.G., Jackson, J.G., Van Den Berg, C.L., Weng, C-N, Lee, A.V., Yee, D. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free. Clinical Cancer Research 1997; 3:103-109.
  9. Gooch, J.L., Van Den Berg, C.L., Yee, D. Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death- proliferative and anti-apoptotic effects. Breast Cancer Research and Treatment 1999; 56:1-10.
  10. Van Den Berg, C., O’Bryant C. Anemias. In: Yee Young L, Koda-Kimble MA, Young L., eds. Applied Therapeutics: The Clinical Use of Drugs. 7th ed. Philadelphia, Lippincott Williams and Wilkins; 2001:84-1-21.
  11. Mamay, C.L., Sion, A.M., Wolf, D.M., Molina, D.M., Van Den Berg, C.L. An inhibitory function for JNK in the regulation of IGF-I signaling in breast cancer. Oncogene 2003; 22:602-614.
  12. Ferguson, H.A., Marietta, P.M. Van Den Berg, C.L. UV induced apoptosis is mediated independent of caspase-9 in MCF-7 cells- a model for cytochrome C resistance. Journal of Biological Chemistry, 2003; 278:45793-45800.
  13. Van Den Berg, C.L. IGF-I influence on breast cancer cell survival. Invited review. Breast Diseases, 2003; 17:49-59.
  14. Mingo-Sion, A.M., Marietta, P.M. Koller, E., Van Den Berg, C.L. Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation and apoptosis in breast cancer cells. Oncogene 2004; 23:596-604.
  15. Mingo-Sion, A.M., Koller, E., Reyland, M.E., Van Den Berg, C.L. mTOR and PKCd interact to regulate stress and ligand mediated phosphorylation of IRS-1 Ser312 in breast cancer cells. Breast Cancer Research and Treatment 2005; 91:259-269.
  16. Ferguson, H.A., Marietta, P.M.  Van Den Berg, C.L.  UV induced apoptosis is mediated independent of caspase-9 in MCF-7 cells – a model for cytochrome C resistance.  Journal of Biological Chemistry 2003; 278:45793-45800.
  17. Popowski, M., Ferguson, H.A. Mingo-Sion, A.M., Koller, E., Knudsen, E.S., Van Den Berg, C.L… Mammalian target of rapamycin (mTOR) mediates insulin-like growth factor breast cancer survival through retinoblastoma protein.  Journal of Biological Chemistry 2008;283:28265-28273.
  18. O’Neal, J.F., Chen, P., Vandenbroek, T.L., Heasley, H.E., Cantrell, M.A., Mitra, S., Van Den Berg, C.L. Jnk2-/- increases tumor development and aneuploidy in the MMTV-Polyoma Middle T Antigen Mammary Tumor Model.  PLoS ONE 2010
  19. Mitra, S. Van Den Berg, C.L.  JNK2 enhances cell migration by regulating EPS8 expression, localization, and protein stability in mammary cancer cells. PMID:21357683 Journal of Biological Chemistry 2011;286:15287-15297.
  20. Nasrazadani, A., Van Den Berg, C.L. JNK2 Regulates GRB2-associated binding protein 2 (GAB2) to Mediate Mouse Mammary Tumor Growth and Metastasis. Genes & Cancer 2011;2:31-45.
  21. Kaoud, T.S., Mitra, S., Lee, S., Taliaferro, J., Cantrell, M., Van Den Berg, C.L., Dalby, K.N. Development of JNK2-selective peptide inhibitors that inhibit breast cancer cell migration. In Press ACS Chemical Biology 2011;6:658-66.
  22. Stone E, Chantranupong L, Gonzalez C, O’Neal J, Rani M, Vandenberg C, Georgiou G. Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapy. PMID:22001609 J Control Release. 2012;158:171-9.
  23. Ippolito, G.C., Hoi, KH., Reddy, S.T., Carroll, S.M. Tobias Rogosch, T., Chrysostomou, C. Ge, X. Van Den Berg, C.L., Zemlin, M., Shultz, L.D. Ellington, A.D., Georgiou G. Extensive Analysis of the Immunoglobulin Repertoires in humanized NOD-scid-IL2Rgnull mice and Comparison with Human Peripheral Blood B cells. PMID: 22558161 PLoS One. 2012;7(4):e3549.
  24. Nancy D. Ebelt, N.D., Cantrell, M., Van Den Berg, C.L. c-Jun N-Terminal Kinases Mediate a Wide Range of Targets in the Metastatic Cascade. PMID: 24349635 Genes & Cancer 2013;9-10:378-87.
  25. Cantrell, M.A., Ebelt, N.D., Pfefferle, A., Perou, C.M., Van Den Berg, C.L. c-Jun N-terminal Kinase 2 Prevents Luminal Cell Commitment in Normal Mammary Glands and Tumors by Inhibiting p53/Notch1 and Breast Cancer Gene 1 Expression. Oncotarget.In Press
    *Priority Report and Topic of Invited Review
  26. Chen, W., Ebelt, N.D., Xhemalce B., Van Den Berg C.L. Miller, K.M. ATM regulation of IL-8 links oxidative stress to cancer cell migration and invasion. eLife In press

Abstracts:

  1. McGill, J., Meador, R.J., Davidson, K.K., Walsh, J.T., Van Den Berg, C.L., Leal, B.Z., Von Hoff, D.D. Evidence of unstable gene amplification in human ovarian cancer cells. Presented at the 5th Intl. Workshop on Chromosomes in Solid Tumors, Tuscon, AZ, Jan 10-12, 1993.
  2. Van Den Berg, C.L., Fields, S.M., Freytes, C.O., LeMaistre, C.F., Koeller, J.M. Clinical outcomes of low-dose granulocyte-colony stimulating factor (G-CSF) in bone marrow transplant (BMT) patients. Proceedings of 4th Intl Symposium Supportive Care in Cancer. OLMA-Messen Conference Centre, St. Gallen, Switzerland, February 24-27, 1993.
  3. McGill, J.R., Walsh, J., Durak, M., Van Den Berg, C.L., Segura, L., Von Hoff, D. Unstable gene amplification found in breast cancers taken directly from patients. Proc Am Assoc Cancer Res, 34:129, 1993.
  4. Van Den Berg, C.L., McGill, J.R., Von Hoff, D.D. Amplified copies of c-myc occur in both extrachromsomal and intrachromosomal sites of a glioblastoma multiforme cell line. Proc Am Assoc Cancer Res, 34:389, 1993.
  5. Van Den Berg, C., McGill, J., Kuhn, J., Walsh, J., De La Cruz, P., Davidson, K., Von Hoff, D. Hydroxyurea pharmacokinetics in nude mice. Proc. Am. Assoc. Cancer Res. 35:428, 1994.
  6. McGill, J.R., Mattern, V., Van Den Berg, C.L., Beitzel, B.F., Chang, D., Dai, A. Hodge, J., Eckhardt, S.G. Mapping and characterization of a microdissected colon cancer double minute chromosome. Proc. Am. Assoc. Cancer Res. 36:540, 1995.
  7. Van Den Berg, C.L., McDermott, M.J., Stroh, C.A., Reitz, B., Cox, G.N., Yee, D. Insulin-like growth factor binding protein-1 (rhIGFBP-1) inhibits growth of breast cancer in vivo. Breast Cancer Res Treat, 37:104 (Supp),1995.
  8. Van Den Berg, C.L., Yee, D. Insulin-like growth factor I (IGF-I) enhances MCF-7 cell growth even in the presence of adriamycin and taxol. Proc Am Assoc Cancer Res 37:220, 1996.
  9. Gooch J.L., Van Den Berg, C.L., Yee D. Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-mediated cell death; proliferative and anti-apoptotic effects. Breast Cancer Research and Treatment 50: 273, 1998.
  10. Van Den Berg, C.L., Mamay C., Molina, M. Mechanisms of Insulin-like growth factor-I (IGF-I) chemoprotective effect in MCF-7 breast cancer cells. Breast Cancer Research and Treatment 50: 274, 1998.
  11. Van Den Berg, C.L., Mamay C., Molina, M. Mechanisms of Insulin-like growth factor-I (IGF-I) chemoprotective effect in MCF-7 breast cancer cells. Proc Am Assoc Cancer Res 41:406, 2000.
  12. Van Den Berg, C.L., Sion, A., Mamay, C.L. Molecular targets for IGF-I protection of irradiated breast cancer cells. Era of Hope. Department of Defense Breast Cancer Research Program Meeting P36-17, 2002.
  13. Ferguson, H.A., Marietta, P.M., Van Den Berg, C.L. UV-induced apoptosis occurs independently of the apoptosome in MCF-7 breast cancer cells. Molecular Mechanisms of Apoptosis, Keystone Symposia 2003; 164.
  14. Mingo-Sion, A.M. Koller, E., Van Den Berg, C.L. Mammalian target of rapamycin predominantly regulates insulin receptor substrate-1 Ser312 phosphorylation in breast cancer cells. Invited Podium Presentation: Protein Kinases and Cancer: The Promise of Molecular-Based Therapies Keystone Symposia 2004; 216.

Facebook link iconMake a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy